204 related articles for article (PubMed ID: 11145895)
21. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by HIV-1-based lentivirus vectors expressing transdominant Rev.
Mautino MR; Keiser N; Morgan RA
J Virol; 2001 Apr; 75(8):3590-9. PubMed ID: 11264348
[TBL] [Abstract][Full Text] [Related]
22. The efficiency of simian foamy virus vector type-1 (SFV-1) in nondividing cells and in human PBLs.
Mergia A; Chari S; Kolson DL; Goodenow MM; Ciccarone T
Virology; 2001 Feb; 280(2):243-52. PubMed ID: 11162838
[TBL] [Abstract][Full Text] [Related]
23. The Rev protein of visna virus is localized to the nucleus of infected cells.
Schoborg RV; Clements JE
Virology; 1994 Jul; 202(1):485-90. PubMed ID: 8009861
[TBL] [Abstract][Full Text] [Related]
24. Identification and visualization of the dimerization initiation site of the prototype lentivirus, maedi visna virus: a potential GACG tetraloop displays structural homology with the alpha- and gamma-retroviruses.
Monie TP; Greatorex JS; Maynard-Smith L; Hook BD; Bishop N; Beales LP; Lever AM
Biochemistry; 2005 Jan; 44(1):294-302. PubMed ID: 15628871
[TBL] [Abstract][Full Text] [Related]
25. Safe two-plasmid production for the first clinical lentivirus vector that achieves >99% transduction in primary cells using a one-step protocol.
Lu X; Humeau L; Slepushkin V; Binder G; Yu Q; Slepushkina T; Chen Z; Merling R; Davis B; Chang YN; Dropulic B
J Gene Med; 2004 Sep; 6(9):963-73. PubMed ID: 15352069
[TBL] [Abstract][Full Text] [Related]
26. Lentiviral and MLV based retroviral vectors for ex vivo and in vivo gene transfer.
Blesch A
Methods; 2004 Jun; 33(2):164-72. PubMed ID: 15121171
[TBL] [Abstract][Full Text] [Related]
27. Generation of lentivirus vectors using recombinant baculoviruses.
Lesch HP; Turpeinen S; Niskanen EA; Mähönen AJ; Airenne KJ; Ylä-Herttuala S
Gene Ther; 2008 Sep; 15(18):1280-6. PubMed ID: 18463689
[TBL] [Abstract][Full Text] [Related]
28. Maedi-visna virus infection in sheep: a review.
Pépin M; Vitu C; Russo P; Mornex JF; Peterhans E
Vet Res; 1998; 29(3-4):341-67. PubMed ID: 9689746
[TBL] [Abstract][Full Text] [Related]
29. Lentiviral transduction of human hematopoietic cells by HIV-1- and SIV-based vectors containing a bicistronic cassette driven by various internal promoters.
Dupuy FP; Mouly E; Mesel-Lemoine M; Morel C; Abriol J; Cherai M; Baillou C; Nègre D; Cosset FL; Klatzmann D; Lemoine FM
J Gene Med; 2005 Sep; 7(9):1158-71. PubMed ID: 15880619
[TBL] [Abstract][Full Text] [Related]
30. Murine and HIV-based retroviral vectors for in vitro and in vivo gene transfer.
Alfa RW; Blesch A
Methods Mol Med; 2006; 129():241-54. PubMed ID: 17085815
[TBL] [Abstract][Full Text] [Related]
31. From retroviral vector production to gene transfer: spontaneous inactivation is caused by loss of reverse transcription capacity.
Carmo M; Panet A; Carrondo MJ; Alves PM; Cruz PE
J Gene Med; 2008 Apr; 10(4):383-91. PubMed ID: 18240154
[TBL] [Abstract][Full Text] [Related]
32. Lentivirus infection of macrophages.
Clements JE; Zink MC; Narayan O; Gabuzda DH
Immunol Ser; 1994; 60():589-600. PubMed ID: 8251596
[TBL] [Abstract][Full Text] [Related]
33. Characterization of an alternative packaging system derived from the cat RD114 retrovirus for gene delivery.
Ghani K; Cottin S; de Campos-Lima PO; Caron MC; Caruso M
J Gene Med; 2009 Aug; 11(8):664-9. PubMed ID: 19507185
[TBL] [Abstract][Full Text] [Related]
34. The rev gene of visna virus is required for productive infection.
Toohey KL; Haase AT
Virology; 1994 Apr; 200(1):276-80. PubMed ID: 7510438
[TBL] [Abstract][Full Text] [Related]
35. Optimisation of a multipartite human immunodeficiency virus based vector system; control of virus infectivity and large-scale production.
Koldej R; Cmielewski P; Stocker A; Parsons DW; Anson DS
J Gene Med; 2005 Nov; 7(11):1390-9. PubMed ID: 16025547
[TBL] [Abstract][Full Text] [Related]
36. A packaging cell line generating CD4-specific retroviral vectors for efficient gene transfer into primary human T-helper lymphocytes.
Thaler S; Schnierle BS
Mol Ther; 2001 Sep; 4(3):273-9. PubMed ID: 11545619
[TBL] [Abstract][Full Text] [Related]
37. Lentiviral siRNAs targeting multiple highly conserved RNA sequences of human immunodeficiency virus type 1.
Chang LJ; Liu X; He J
Gene Ther; 2005 Jul; 12(14):1133-44. PubMed ID: 15750613
[TBL] [Abstract][Full Text] [Related]
38. The vif gene of maedi-visna virus is essential for infectivity in vivo and in vitro.
Kristbjörnsdóttir HB; Andrésdóttir V; Svansson V; Torsteinsdóttir S; Matthíasdóttir S; Andrésson OS
Virology; 2004 Jan; 318(1):350-9. PubMed ID: 14972560
[TBL] [Abstract][Full Text] [Related]
39. Role of a heterologous retroviral transport element in the development of genetic complementation assay for mouse mammary tumor virus (MMTV) replication.
Rizvi TA; Ali J; Phillip PS; Ghazawi A; Jayanth P; Mustafa F
Virology; 2009 Mar; 385(2):464-72. PubMed ID: 19157480
[TBL] [Abstract][Full Text] [Related]
40. Reducing mobilization of simian immunodeficiency virus based vectors by primer complementation.
Grunwald T; Pedersen FS; Wagner R; Uberla K
J Gene Med; 2004 Feb; 6(2):147-54. PubMed ID: 14978768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
